MIRM Dec 2024 35.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

4.2000

-0.0400

(-0.94%)

As of 09:30AM EDT. Market open.

Loading interactive chart...

Investor's Business Daily
MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
After earnings more than doubled in 2023, analysts expect MercadoLibre's growth to remain strong, up 78% this year.
Business Wire
Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
FOSTER CITY, Calif., June 28, 2024--Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
Investor's Business Daily
Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling
This biotech stock nears a buy point after an explosive move following positive drug trial news. Sales have grown by triple-digits for seven quarters.